Patent holdings for IPC class A61K 31/197

Total number of patents in this class: 2181

10-year publication summary

196
213
196
195
231
235
252
253
204
61
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
SBI Pharmaceuticals Co., Ltd.
108
68
Pharnext
106
50
The Regents of the University of California
18943
38
GW Research Limited
402
24
Osmotica Kereskedelmi ES Szolgaltato Kft
23
21
Société des Produits Nestlé S.A.
9672
20
DSM IP Assets B.V.
5856
18
Quadriga Biosciences, Inc.
21
16
Amneal Pharmaceuticals LLC
89
14
neopharma Japan Co., Ltd.
18
14
Allergan, Inc.
2600
13
University of Florida Research Foundation, Inc.
3883
13
Ovid Therapeutics Inc
151
13
Theravance Biopharma R&D IP, LLC
550
13
Diamyd Medical AB, AKA Diamyd
27
12
Alpheus Medical, Inc.
33
12
National Center for Child Health and Development
71
11
Medisca Pharmaceutique Inc.
128
10
Centre National de La Recherche Scientifique
9632
9
Mayo Foundation for Medical Education and Research
2981
9
Other owners 1783